- AU$20.02m
- AU$18.54m
- AU$0.03m
Annual income statement for BTC Health, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.095 | 0.013 | 0.016 | 0.01 | 0.029 |
| Selling / General / Administrative Expenses | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 0.671 | 0.561 | 0.676 | 0.675 | 0.423 |
| Operating Profit | -0.576 | -0.548 | -0.66 | -0.666 | -0.393 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -0.576 | -10.2 | 1.06 | 3.98 | 0.035 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.576 | -10.2 | 1.06 | 3.98 | 0.035 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.576 | -10.2 | 1.06 | 3.98 | 0.035 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.576 | -10.2 | 1.06 | 3.98 | 0.035 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.002 | -0.036 | 0.003 | 0.012 | 0 |
| Dividends per Share |